The Journal of Clinical PharmacologyPharmacology & ToxicologyPeer-reviewed journal article
Decoupling CAR-T Expansion, Conversion, and Decay Timing: Physiologically Aligned Semi-Mechanistic Modeling with Smooth Gating and a Cauchy Likelihood Residual Model
Abstract
Chimeric antigen receptor (CAR) T-cell therapies exhibit complex cellular kinetics characterized by rapid expansion, contraction, and long-term persistence, often with substantial inter-individual variability, frequent below-quantification (BLQ) observations, and occasional influential data points. These features can destabilize inference under Gaussian residual assumptions and motivate robust, likelihood-based approaches that can jointly accommodate outliers and censoring. In prior work, we showed that combining Students t residuals with likelihood-based BLQ handling (M3 censoring) improves robustness in CAR-T cellular kinetics modeling; however, implementing Students t censoring likelihoods is not straightforward in all modeling platforms because the Students t cumulative distribution function (CDF) lacks a simple elementary closed-form. Here, we evaluated the Cauchy residual likelihood as a practical, heavy-tailed alternative to Students t that provides closed-form expressions for both the probability density function (PDF) and CDF. In a two-compartment IV pharmacokinetic simulation with terminal-phase outlier contamination, Cauchy residuals preserved stable parameter recovery comparable to Students t while avoiding the bias and instability observed under Normal residuals. In a real-data integrated CAR-T cellular kinetics application fitted with full Bayesian inference and likelihood-based BLQ handling, replacing Students t with Cauchy yielded highly concordant posterior inference and similar subject-level predictions. We further extended a semi-mechanistic CAR-T cellular kinetics framework by replacing piecewise switching with smooth S-shaped time-varying rate functions and allowing process-specific transition times. Full Bayesian posterior summaries supported asynchronous transition timing, including earlier conversion relative to expansion and later decay-related transitions. Collectively, these results support Cauchy likelihoods as an implementation-friendly robust option and demonstrate that smooth, process-specific transition modeling can enhance physiological plausibility for CAR-T kinetics.
- research focus: drug response / drug discovery
- approach: statistical model
- approach: Bayesian inference
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 49th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Delay Differential Equation (DDE) Modeling of CAR-T Cellular Kinetics: Application to BCMA-Targeted (Ide-cel, Orva-cel) and CD19-Targeted (Liso-cel) Therapies
Yiming Cheng, Yan Li·Journal of Pharmaceutical SciencesPeer-reviewed·May 27, 2026
- Response to CAR T cell therapy can be explained by ecological cell dynamics and stochastic extinction events
G. J. Kimmel, F. L. Locke, P. M. Altrock·bioRxiv·Mar 31, 2020
- Mathematical deconvolution of CAR T-cell proliferation and exhaustion from real-time killing assay data
P. Sahoo, X. Yang, … R. C. Rockne·bioRxiv·Nov 9, 2019
- A mechanistic model for dynamics between CAR T cells and target cells captures features that determine killing profiles
Suriya Selvarajan, Kevin L. Scrudders, … Shalini T. Low-Nam·bioRxiv·Jun 24, 2025
- Modeling predicts differences in CAR T cell signaling due to biological variability
Vardges Tserunyan, Stacey D. Finley·bioRxiv·Jan 14, 2022
- Toxicity Management in CAR T cell therapy for B-ALL: Mathematical modelling as a new avenue for improvement.
Shalla Hanson, David Robert Grimes, … Arturo Araujo·bioRxiv·Apr 22, 2016